William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Viking Therapeutics (VKTX) Announces Pricing of $550 Mln Public Offering of Common Stock
-
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
-
Form X-17A-5 WILLIAM BLAIR & COMPANY For: Dec 31
-
EverQuote to Participate in Upcoming Investor Conferences
-
Analysis-Investors cautiously welcome Nigeria's big rate hike
-
Bandwidth Announces Fourth Quarter and Full Year 2023 Financial Results, Exceeding Revenue and Profitability Guidance
-
William Blair Downgrades Thoughtworks Holding (TWKS) to Market Perform, 'Supply challenges'
-
Janux Therapeutics (JANX) Announces Proposed $175M Share Offering
-
Janux Therapeutics Announces Proposed Public Offering of Common Stock
-
Viking Therapeutics (VKTX) Announces $350M Proposed Public Offering of Common Stock
-
Viking Therapeutics Announces Proposed Public Offering of Common Stock
-
Prime Pensions Announces Strategic Investment from Lightyear Capital for Next Phase of Growth
-
Form N-CSR WILLIAM BLAIR FUNDS For: Dec 31
-
Sealed Air (SEE) rumored to be a takeover target
-
William Blair Upgrades Carvana (CVNA) to Outperform, 'Strong End to Transformative Year'
-
SKYSERVICE AND FONTAINEBLEAU DEVELOPMENT PARTNER TO DEVELOP NEW FORT LAUDERDALE FBO
-
QuidelOrtho (QDEL) pops 6% after board fires CEO
-
William Blair Starts Keros Therapeutics (KROS) at Outperform
-
William Blair Upgrades ARS Pharmaceuticals Inc (SPRY) to Outperform, 'Sets Up Second Half 2024 Approval and Launch'
-
ReCode Therapeutics to Participate in February Conferences
-
William Blair Downgrades Kinnate Biopharma (KNTE) to Market Perform
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Quick Quack Car Wash explores minority stake sale, sources say
-
William Blair Upgrades Inogen, Inc (INGN) to Outperform, 'A Breath of Fresh Air'
-
Atlanticus Closes Option in connection with Offering of Senior Notes
-
Holding(s) in Company
-
William Blair Downgrades Quidel Corp. (QDEL) to Market Perform 'on Near-Term Headaches'
-
Rekor Systems Announces Full Exercise and Closing of Underwriters' Option in Connection with its Underwritten Public Offering of Common Stock
-
LPL Financial (LPLA) Acquires Atria Wealth Solutions
-
LPL Financial to Acquire Atria Wealth Solutions
-
Biogen sees flat 2024 sales, pick up in Alzheimer's drug demand
-
William Blair on 2U, Inc. (TWOU): 'see a relatively balanced risk/reward setup following the implied sell-off'

